Status:
COMPLETED
A Study Evaluating Botulinum Toxin Type A in Subjects With Postherpetic Neuralgia
Lead Sponsor:
Allergan
Conditions:
Postherpetic Neuralgia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
4-month study including a 30-day baseline phase
Eligibility Criteria
Inclusion
- Postherpetic neuralgia for more than 3 months after the healing of a herpes zoster skin rash.
Exclusion
- Previous use of botulinum toxin of any serotype or immunization to any botulinum toxin serotype.
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT00168441
Start Date
June 1 2004
End Date
June 1 2005
Last Update
May 30 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.